14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC

Key Takeaways

  • Innate immunity (barriers, phagocytes, NK cells, complement, pattern-recognition receptors such as Toll-like receptors) is immediate and non-specific; adaptive immunity (B and T cells) is specific, slower at first and leaves memory.

  • MHC class I (all nucleated cells) presents intracellular peptides to CD8 cytotoxic T cells; MHC class II (antigen-presenting cells) presents extracellular peptides to CD4 helper T cells.

  • IgM is the first antibody made and the best complement activator; IgG is the most abundant, crosses the placenta and dominates secondary responses; IgA protects mucosae and is in breast milk; IgE mediates allergy and helminth immunity.

  • The classical pathway starts with antigen-antibody complexes (C1q), the lectin pathway with mannose-binding lectin, and the alternative pathway spontaneously on microbial surfaces; all converge on C3, and C5b-9 forms the membrane attack complex.

  • IL-1, IL-6 and TNF-alpha drive fever and the acute-phase response; IL-2 expands T cells; IFN-gamma activates macrophages (Th1); IL-4, IL-5 and IL-13 drive IgE and eosinophils (Th2); IL-10 and TGF-beta suppress.

Last updated: October 2026

Why this area matters

The TOS lists "innate and acquired immunity (functions of immune system, events in the immune response, humoral versus cell-mediated immunity, antigen and antibody interaction), role of cytokines, MHC class I and II". These basics explain how vaccines work, why newborns rely on maternal IgG and breast milk IgA, what serologic tests mean (dengue IgM, HBsAg, anti-HBs) and how immunodeficiencies present.

Innate and adaptive immunity

FeatureInnate immunityAdaptive (acquired) immunity
ComponentsSkin and mucosal barriers, lysozyme, stomach acid, neutrophils, macrophages, dendritic cells, NK cells, complement, acute-phase proteins, interferonsB lymphocytes (antibodies) and T lymphocytes (CD4 helper, CD8 cytotoxic, regulatory)
RecognitionGermline pattern-recognition receptors (Toll-like receptors) detecting PAMPs such as LPS, flagellin and viral nucleic acidsHighly diverse antigen receptors from V(D)J recombination
SpeedMinutes to hoursDays on first exposure (primary response)
MemoryNoneMemory: faster, larger secondary response, the basis of vaccination

NK cells kill virus-infected and tumor cells that have lost MHC class I (the "missing self" mechanism) and cells coated with IgG (antibody-dependent cellular cytotoxicity).

Events in an immune response

  1. Recognition and capture: dendritic cells take up antigen at the site of entry and carry it to the lymph nodes.
  2. Presentation: peptides are displayed on MHC molecules to naive T cells.
  3. Activation: this needs two signals: the T-cell receptor binding peptide-MHC (signal 1) plus co-stimulation by CD28 binding B7 (CD80/86) (signal 2). Without signal 2, the T cell becomes anergic.
  4. Clonal expansion and differentiation: IL-2 drives proliferation. CD4 cells differentiate into Th1, Th2, Th17 or follicular helper cells, and CD8 cells into cytotoxic cells.
  5. Effector phase:
    • Humoral: B cells, helped by T follicular helper cells through CD40L-CD40, undergo class switching and affinity maturation in germinal centers and become plasma cells.
    • Cell-mediated: cytotoxic T cells kill infected cells with perforin, granzymes and Fas ligand, and Th1 cells activate macrophages.
  6. Contraction and memory: most effector cells die, and memory B and T cells remain.
Humoral immunityCell-mediated immunity
Antibodies from B cells and plasma cellsT cells (CD8 killing; CD4 Th1 macrophage activation)
Best against extracellular bacteria, toxins and free virusesBest against intracellular pathogens (viruses, mycobacteria, fungi), tumors and grafts
Effector actions: neutralization, opsonization, complement activation, ADCCEffector actions: cytotoxicity, delayed-type hypersensitivity, granulomas
Tests: serologyTests: tuberculin skin test, interferon-gamma release assays

Antibodies and antigen-antibody interactions

An antibody has two identical heavy and two identical light chains (kappa or lambda). The Fab fragment binds antigen through the variable regions, which contain the hypervariable regions or CDRs. The Fc fragment determines class functions: complement binding and Fc receptor binding.

ClassKey features
IgGMost abundant in serum; crosses the placenta and protects newborns for about 6 months; main antibody of the secondary response; opsonizes and activates complement; subclasses IgG1 to IgG4
IgMFirst antibody in a primary response; a pentamer (10 binding sites), so the best complement activator; B-cell receptor (monomer); a positive IgM suggests recent infection (dengue IgM, anti-HAV IgM, anti-HBc IgM)
IgAMucosal antibody; secretory IgA is a dimer with J chain and secretory component; in breast milk and colostrum; does not fix complement well
IgEBinds mast cells and basophils; allergy (type I hypersensitivity) and helminth defense
IgDOn naive B cells with IgM; function poorly defined

Antigen-antibody reactions are non-covalent: hydrogen bonds, electrostatic, van der Waals and hydrophobic forces. Their strength is affinity for a single site and avidity overall. Laboratory uses include:

  • agglutination (blood typing, Widal test);
  • precipitation;
  • ELISA;
  • immunofluorescence;
  • lateral-flow rapid tests;
  • the Coombs test for antibody-coated red cells.

The complement system

PathwayTriggerEarly components
ClassicalAntigen-antibody complexes (IgM, IgG)C1q, C1r, C1s, C4, C2
LectinMannose-binding lectin on microbial sugarsMASPs, C4, C2
AlternativeSpontaneous C3 hydrolysis on microbial surfacesC3, factor B, factor D, properdin

All three converge on C3 convertase. C3b is an opsonin. C3a and C5a are anaphylatoxins, and C5a is also a neutrophil chemoattractant. C5b-9 forms the membrane attack complex.

Regulators: C1 esterase inhibitor (its deficiency causes hereditary angioedema), and decay-accelerating factor and CD59 (their loss causes paroxysmal nocturnal hemoglobinuria).

Deficiencies: early classical components (C1, C2, C4) predispose to SLE; C3 deficiency to severe pyogenic infections; and C5 to C9 deficiency to recurrent Neisseria infections.

Cytokines

CytokineMain sourceMain actions
IL-1, TNF-alpha, IL-6MacrophagesFever, acute-phase response (IL-6 drives CRP and hepcidin), endothelial activation; TNF causes cachexia and septic shock
IL-8 (CXCL8)Macrophages, endotheliumNeutrophil chemotaxis
IL-12Macrophages, dendritic cellsDrives Th1 differentiation
IL-2T cellsT-cell proliferation (blocked by calcineurin inhibitors such as cyclosporine)
IFN-gammaTh1 cells, NK cellsActivates macrophages (granulomas); increases MHC expression
IL-4, IL-5, IL-13Th2 cellsIgE class switching (IL-4), eosinophils (IL-5), mucus
IL-17Th17 cellsNeutrophil recruitment (psoriasis, autoimmunity)
IL-10, TGF-betaRegulatory T cells, M2 macrophagesSuppress inflammation; TGF-beta drives fibrosis and IgA class switching
Type I interferons (alpha, beta)Virus-infected cellsAntiviral state; activate NK cells

MHC (HLA) molecules

FeatureMHC class I (HLA-A, -B, -C)MHC class II (HLA-DR, -DP, -DQ)
Found onAll nucleated cells (not red cells)Antigen-presenting cells: dendritic cells, macrophages, B cells
Peptide sourceEndogenous (cytosolic): viral and tumor proteins, processed by the proteasome and moved by TAP into the ERExogenous: endocytosed proteins in endosomes; invariant chain blocks the groove until loading
T-cell partnerCD8 cytotoxic T cellsCD4 helper T cells
StructureAlpha chain plus beta-2-microglobulinAlpha and beta chains

MHC genes on chromosome 6 are highly polymorphic, which matters for transplant matching. Some disease associations are HLA-B27 (ankylosing spondylitis), HLA-DR3 and DR4 (type 1 diabetes) and HLA-DQ2 and DQ8 (celiac disease).

Immunity and vaccines

  • Active immunity comes from infection or vaccination. It is slow to develop but long-lasting, with memory.
  • Passive immunity comes from maternal IgG, breast-milk IgA, or immune globulins (rabies, tetanus and hepatitis B immune globulin, antivenom). It is immediate but temporary.
  • Live attenuated vaccines (MMR, BCG, oral polio, varicella) induce strong cellular immunity but are generally avoided in pregnancy and severe immunodeficiency.
  • Inactivated, subunit, toxoid and conjugate vaccines need boosters.
  • Conjugating a polysaccharide to a protein carrier (Hib, pneumococcal conjugate) converts a T-independent response into a T-dependent one that works in infants under 2 years.
Test Your Knowledge

A virus-infected hepatocyte displays viral peptides that are recognized by cytotoxic T lymphocytes. Through which molecule and pathway are these peptides presented?

A

CD1, after lipid processing in lysosomes

B

MHC class I, after proteasomal processing and TAP transport into the ER

C

MHC class II, after endosomal processing with the invariant chain and HLA-DM loading

D

Free in the cytosol, without any MHC molecule

Test Your Knowledge

A 5-day-old baby has antibodies against measles in his blood, although he has never been infected or vaccinated. Which antibody class explains this, and what kind of immunity is it?

A

Maternal IgG that crossed the placenta, giving passive immunity

B

Maternal IgA absorbed from colostrum into the blood, giving active immunity

C

Fetal IgM made in response to maternal antigens, giving active immunity

D

Fetal IgE produced after birth, giving passive immunity

Test Your Knowledge

A boy has had two episodes of meningococcal meningitis. Deficiency of which complement components is most likely?

A

The terminal components C5 to C9 that form the membrane attack complex

B

Decay-accelerating factor (CD55)

C

C1 esterase inhibitor

D

Early classical pathway components C1, C2 and C4 that start the cascade and activate C3

Sections you finish are checked off in the contents.